Speculative Swine Flu Names Seeing Reversal (NVAX, GNBT)

Posted in General 
May 1st, 2009

Novavax (NVAX) is down over 10% this morning as investors continue to bail out of their speculative swine flu (or any flu and vaccine) stocks. At $2.12 before the bell, this was as high as $3.88 earlier this week.  As of 8:46 we have seen 223,000 shares trade hands.

Generex Biotechnology Corp. (GNBT) is also getting hit again and its shares are down over 6% at $0.369 as of 8:46 on about 79,000 shares.  This one was at $0.70 earlier this week.

I heard that swine flu tastes a lot like chicken.

JON C. OGG

Comments are closed

-->